Table 2.
Compliance and loss to follow-up in re-randomization trials
Number of trials reporting measure | Median (range) | |
---|---|---|
Percent of episodes not complying with treatment protocol | 5 | 1.7 (0–8.9) |
Percent of episodes excluded from analysis due to missing data | ||
Overall mortality | 5 | 0 (0–0) |
Infection-related mortality | 4 | 0 (0–0) |
Hospitalization >10 days | 3 | 0 (0–0) |
Duration of grade IV neutropenia | 2 | 0 (0–0) |
Time to recovery from fever | 3 | 0 (0–0) |